Indena

Activities: Ingredients Research & Development Nutraceutical
Indena

Trending Articles

  1. CellCarta adds Tempus to companion diagnostic commercialisation network CellCarta has partnered with Tempus to expand its CDx Commercialization Lab Network, giving biopharma sponsors a route from companion diagnostic development and regulatory...
  2. Fridge-free tetanus-diphtheria vaccine passes first human trial Stablepharma's SPVX02 vaccine remains stable at 30°C for two years, new Phase I data shows, easing cold-chain dependence
  3. FDA escalates action against Dabur India over systemic data-integrity and cGMP failures The US FDA has issued a warning letter to Dabur India following an inspection that identified falsified records, missing laboratory data, inadequate cleaning and process...
  4. Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling New X2 and S2 Series centrifuges combine precise performance with improved sustainability for research, biopharma and clinical laboratories
  5. SCHOTT Pharma expands portfolio for sensitive biologics with cartriQ BioPure The new high‑performance sterile glass cartridge is engineered for stability of complex biologics across their shelf life. It complements EVERIC pure vials and syriQ BioPure...

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

Related Content

Microbiology
Nestlé Health Science and IdB partner to bring VOWST to Europe

Nestlé Health Science and IdB partner to bring VOWST to Europe

Nestlé Health Science and IdB Holding have signed a licensing agreement to seek EMA approval for VOWST, the only FDA-approved oral live biotherapeutic for recurrent C. diff prevention
Marketing
Indena to highlight expanded HPAPI, ADC and peptide drug conjugate capabilities at DCAT Week 2026

Indena to highlight expanded HPAPI, ADC and peptide drug conjugate capabilities at DCAT Week 2026

Italian CDMO Indena will showcase its high-potency API manufacturing expertise and growing oncology-focused capabilities at DCAT Week in New York, including ten commercial HPAPIs in production and advancing work in antibody-drug and peptide drug conjugates
Manufacturing
Indena showcases expanded capabilities, innovative APIs and ADC partnership at CPHI 2025

Indena showcases expanded capabilities, innovative APIs and ADC partnership at CPHI 2025

Indena, a global leader in plant-derived active pharmaceutical ingredients (APIs), will present its latest technological and manufacturing advances at CPHI 2025 (Frankfurt, 28–30 October)
Manufacturing
Indena accelerates CDMO innovation with advanced facilities and cutting-edge tech

Indena accelerates CDMO innovation with advanced facilities and cutting-edge tech

In 2025, Indena completed several facility upgrades that have increased the quality, versatility and reliability of the CDMO services it offers for partners
Research & Development
Indena and TCG GreenChem join forces to advance next-generation ADC technologies

Indena and TCG GreenChem join forces to advance next-generation ADC technologies

Indena and TCG GreenChem are pleased to announce a new strategic collaboration aimed at accelerating the development of innovative and market-ready payload-linkers: the key component of antibody-drug conjugates (ADCs)
Pharmaceutical
CDMO services and innovative products for pharmaceutical industry

CDMO services and innovative products for pharmaceutical industry

The Italian company stands as a reliable partner for pharmaceutical and biotech clients in the Japanese market
Ingredients
Indena becomes first API manufacturer to receive European CEP certification

Indena becomes first API manufacturer to receive European CEP certification

Its CBD extract is the first to receive the European Pharmacopoeia Certificate of Eligibility from the European Directorate for the Quality of Medicines (EDQM)
Subscribe now